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ABSTRACT
Migraine is a commonly-occurring primary headache disorder that is often comorbid with
many conditions, including depression, anxiety, and sleep disorders. Previous research has
shown that sleep problems are common among migraineurs, with insomnia being the most
prevalent. Insomnia in migraineurs has many possible causes, including inadequate sleep
hygiene, or participating in behaviors that are not conducive to sleep. Modifying sleep hygiene
behavior has been shown to be effective in reducing migraine intensity and frequency, but
research characterizing the specific sleep hygiene behaviors of migraineurs is limited. The
present study sought to identify problematic sleep behaviors and their association with episodic
migraine so as to inform the development and refinement of behavioral sleep interventions to
reduce migraine frequency, intensity, and disability. The present study also explored anxiety and
depression and their relation to migraine, sleep hygiene, and insomnia among college students, a
population of interest because of their high rates of migraine, sleep disturbance, and
psychological comorbidities.
The sample consisted of 323 college students with a mean age of 19.28 years (SD =
3.38), with 84 (26%) meeting ICHD-II criteria for episodic migraine and 8 (2.5%) for chronic
migraine. Episodic migraineurs reported significantly poorer overall sleep hygiene compared to
controls (Sleep Hygiene Index M = 38.24 [SD = 6.71] v. 36.54 [SD = 6.06], p < .05). After
controlling for symptoms of insomnia, anxiety, and depression, which were significantly higher
among migraineurs, however, these differences were rendered nonsignificant. Among episodic
migraineurs, linear regression analyses showed that poorer sleep hygiene significantly predicted
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headache-related disability but not migraine severity or frequency. An argument is presented that
sleep hygiene is less important among episodic than chronic migraineurs, and directions for
future research are discussed.
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Examining the Sleep Hygiene Behaviors of Migraineurs in a University Setting

Introduction
Migraine Diagnosis
Migraine is a commonly-occurring primary headache disorder that can be extremely
disabling and can have a major impact on many areas of an individual’s life. Migraine has a
lifetime prevalence of 12% among the general population and 18-20% among women (Fukui et
al., 2008; Jette, Patten, Williams, Becker, & Wiebe, 2008). Many studies have shown that
migraine is up to four times more common among women than among men (Jelinski et al., 2006;
Lyngberg, Rasmussen, Jorgensen, & Jensen, 2005; Stewart, Lipton, Celentano, & Reed, 1992)
and is most prominent between the ages of 25 and 44 years (Lipton et al., 2002; Pryse-Phillips et
al., 1992). The World Health Organization has ranked migraine as number 19 among all diseases
worldwide that cause disability (Leonardi, Musicco, & Nappi, 1998).
Diagnostic criteria for migraine and other headache disorders are outlined in the
International Classification of Headache Disorders, 2nd Edition (ICHD-II; Headache
Classification Subcommittee of the International Headache Society [IHS], 2004). Migraine is
defined as “a recurrent headache disorder manifesting in attacks lasting 4-72 hours” either
untreated or unsuccessfully treated (IHS, 2004, p. 24). Typical characteristics of migraine attacks
are “unilateral location, pulsating/throbbing quality, moderate or severe intensity, aggravation by
routine physical activity, and association with nausea and/or vomiting and/or photophobia and
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phonophobia” (IHS, 2004, p. 24-25). Migraine can be divided into two major sub-types:
migraine without aura (1.1) and migraine with aura (1.2). Though less common than migraine
without aura, migraine with aura is distinctively characterized by neurological symptoms (aura)
that are usually visual innature and precede or sometimes accompany the other features of
migraine. Typical aura (1.2.1) consists of at least one of the following: “fully reversible visual
symptoms including positive features (e.g. flickering lights, spots or lines) and/or negative
features (i.e. loss of vision), fully reversible sensory symptoms including positive features (i.e.
pins and needles) and/or negative features (i.e. numbness), or fully reversible dysphasic speech
disturbance” (IHS, 2004, p. 26-27).
Comorbidity of Migraine
The prevalence of co-occurring psychological disorders (i.e., psychological comorbidity)
in migraineurs has been explored frequently. Migraine is comorbid with disorders such as major
depressive disorder, generalized anxiety disorder, panic disorder, bipolar disorder, and social
phobia (Breslau & Davis, 1992, 1993; Breslau, Davis, Schultz, & Peterson, 1994; Breslau,
Lipton, Stewart, Schultz, & Welch, 2003; Breslau, Shultz, Stewart, Lipton, & Welch, 2001;
Ettinger, Reed, Goldberg, & Hirschfeld, 2005; Lipton, Hamelsky, Kolodner, Steiner, & Stewart,
2000; McIntyre et al., 2006; Stewart, Breslau, & Keck, 1994). Conflicting findings exist
pertaining to the comorbidity of substance use disorders with migraine (Jette et al., 2008;
Saunders, Merikangas, Low, Von Korff, & Kessler, 2008; Swartz, Pratt, Armenian, Lee, &
Eaton, 2000). The most common classes of psychological disorders that are comorbid with
migraine are depressive and anxiety disorders (Lanteri-Minet, Radat, Chautard, & Lucas, 2005;
Oedegaard et al., 2006). Several large-scale population-based studies have shown that
migraineurs are two to four times more likely to suffer from depression and anxiety disorders
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than are individuals in the general population without migraine (Boardman, Thomas, Millson, &
Croft, 2005; Breslau et al., 1994, 2003; Jette et al., 2008; Merikangas, Angst, & Isler, 1990;
Ohayon, 2004), with panic disorder and phobias being the most common comorbid anxiety
disorders (Breslau & Davis, 1992; Breslau et al., 2001; Radat & Swendsen, 2005; Stewart et al.,
1994).
A bidirectional relationship has been implicated for migraine and depression, suggesting
that each disorder increases risk for onset of the other and arguing against the traditional notion
that depression is merely a response to living with disabling migraines (Breslau et al., 1994,
2003). A bidirectional relationship has also been implicated between migraine and panic disorder
(Breslau et al., 2001), although further research is needed to clarify the temporal relationship
between anxiety disorders and migraine. These findings suggest that psychological comorbidities
may share etiological pathways with migraine. As one example, reduced serotonergic
transmission is common in both migraine and anxiety/depression (Breslau et al., 1994;
Panconesi, 2008), and both conditions respond favorably to medications that increase
serotonergic activity.
Psychological comorbidities in migraineurs have become an increasing concern since the
World Health Organization has ranked both migraine and major depressive disorder as leading
causes of disability worldwide (Jette et al., 2008; Simon, 2003; Ustun & Kessler, 2002), with
anxiety disorders also ranked as highly disabling among psychological disorders (Kessler, Chiu,
Demler, & Walters, 2005). Studies have already shown that migraine (with and without
psychological comorbidity) causes a significant reduction in quality of life, loss of productivity,
and increased health care costs, among other practical liabilities (Hu, Markson, Lipton, Stewart,
& Berger, 1999; Lipton et al., 2000; Von Korff, Stewart, Simon, & Lipton, 1998; Baskin &
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Smitherman, 2009). Furthermore, it is important to identify psychological comorbidities in
migraineurs because these comorbidities may complicate the diagnosis and treatment of
migraine, affect treatment adherence, or alter the course of migraine (Baskin, Lipchik, &
Smitherman, 2006; Baskin & Smitherman, 2009).
Role of Sleep Dysfunction in Migraine
In addition to research on affective comorbidities, headache researchers have begun to
look at other comorbidities (Peres, Young, Kaup, Zukerman, & Silberstein, 2001; Peres,
Zukerman, Young, & Silberstein, 2002). Some of the most common other comorbidities that
accompany migraine are sleep disorders. Sleep disorders that are comorbid with migraine and
other headache include circadian rhythm disorders (Ohayon, 2005), chronic snoring (Jennum,
Hein, Suadicani, & Gyntelberg, 1994), sleep apnea (Ulfberg, Carter, Talback, & Eding, 1996)
and other sleep-related breathing disorders (Olson, King, Hensley, & Saunders, 1995),
parasomnias (Goder et al., 2003), and hypersomnia (Goder et al., 2003). The most common sleep
disorder in migraineurs, however, is insomnia (Maizels & Burchette, 2004; Ohayon, 2004; Paiva,
Martins, Batista, Esperanca, & Martins, 1994; Rains & Poceta, 2006; Rothrock, Patel, Lyden, &
Jackson, 1996).
Early research on headache and sleep was unclear as to whether sleep disturbance
consistently accompanies migraine in the absence of other psychological comorbidities or
whether sleep disturbance is a complication of co-occurring psychological disorders (Wright,
1871). However, current research has shown that a disproportionate prevalence of sleep
disturbances in migraine persists even after controlling for psychological comorbidities such as
anxiety and depression (Vgontzas, Cui, & Merikangas, 2008) and is thus not merely a
consequence of affective comorbidities. Not only has migraine been implicated to precede sleep
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disturbance (Inamorato, Minatti-Hannuch, & Zukerman, 1993; Marcus, 2006), but insomnia and
the aforementioned sleep disturbances also often function as “triggers” for migraine (Fukui et al.,
2008; Kelman, 2007; Spierings, Ranke, & Honkoop, 2001).
A migraine trigger is an environmental or physiological event that produces (or
predisposes an individual to) a migraine attack. Many studies have examined the different types
of migraine triggers, though most of them rely on retrospective recall rather than prospective
data. Kelman (2007) found that 75.9% of migraineurs reported experiencing triggers, with 35.5%
reporting that they occurred at least frequently and 94.6% reporting that they occurred at least
occasionally. Sixty-one percent of patients reported having between four and nine triggers (M =
6.7; Mdn = 7.7). The most common triggers reported were stress, hormonal changes (in women),
not eating, weather changes, and sleep disturbances, all of which were present in roughly 50% of
the migraine sample. Another study by Fukui et al. (2008) found that dietary factors, sleep
disturbance, environmental factors, and stress were among the most common migraine triggers.
Marcus (2003) found that 26% of approximately 300 headache patients reported changes in sleep
as a trigger for migraine. Similarly, Jerusalimschy and Moreira-Filho (2002) found that 49% of
headache patients reported sleep disturbance as a trigger for their headache. More specifically,
Spierings et al. (2001) found that 74% reported sleeplessness as a headache trigger. Taken
together, and despite large variability in estimates, these studies provide strong support for the
notion that sleep disturbances are common among migraineurs and function frequently as
migraine triggers (for ¼ to ¾ of migraineurs).
The rate at which sleep disturbances co-occur with migraine (even when controlling for
other comorbidities) is suggestive of a potential shared etiology between these conditions. It has
been suggested that migraine can occur because of circadian changes in levels of serotonin,
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melatonin, and magnesium (Dodick, Eross, & Parish, 2003; Marcus, 2006). At night, circulating
tryptophan is converted to serotonin in the pineal gland, which is then converted to melatonin.
Serotonin and melatonin released from the pineal gland influence activity of the
trigeminovascular system (Marcus, 2006; Toglia, 2001). Altered neuronal activity in the
trigeminovascular system (specifically the trigeminal nerve, spinal trigeminal nucleus, and
thalamus) elicits migraine through nociceptive afferents to the brain and meningeal blood
vessels, which causes the perception of pain (Messlinger, 2009). Although evidence is growing
that sleep and migraine share common pathophysiology, further research is needed to clarify the
mechanisms that underpin this relationship.
Insomnia in Migraine
Insomnia is typically defined in research studies as a sleep disturbance characterized by
getting ≤ 6 hours of continuous sleep, difficulty falling asleep or staying asleep, early morning
awakening or non-restorative sleep, and daytime consequences such as sleepiness. The
International Classification of Sleep Disorders- 2nd edition (ICSD-2; AASM, 2005) classifies
insomnia by its severity: mild, moderate, or severe. With mild insomnia there is little to no
evidence of impairment in functioning, with moderate insomnia there is mild to moderate
evidence of impairment in social or occupational functioning, and with severe insomnia there is
obvious and severe impairment in functioning. All severities are associated with feelings of
restlessness, irritability, mild anxiety, daytime fatigue, and tiredness (AASM, 2005).
Insomnia or insomnia-like symptoms are often present in migraineurs. Fukui et al. (2008)
found that among reported sleep disturbances, lack of sleep occurred in 61.5% of migraineurs.
More specifically, in one of the largest samples of migraineurs studied to date (Kelman & Rains,
2005), 38% of 1,283 migraineurs suffered from insomnia-like symptoms (sleeping no more than
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6 hours per night), compared with 10% of the general population (AASM, 2005). Thirty-one
percent of migraineurs reported problems falling asleep and 39% reported problems staying
asleep. In this study, greater frequency of migraine was related to shorter sleep episodes, in that
patients with chronic migraine reported shorter sleep episodes than those with episodic migraine.
Gori et al. (2005) also found that poor sleep was reported by 64% of migraineurs compared to
33% of controls. The most commonly reported sleep disturbance was inability to fall asleep.
Although the range of these percentages is large, it is clear that migraineurs are significantly
more likely to suffer from insomnia-like symptoms than are those without migraine. Indeed, the
finding of insomnia as the most commonly reported sleep disturbance is consistent throughout
the migraine literature (Blau, 1990; Calhoun & Ford, 2007; Calhoun, Ford, Finkel, Kahn, &
Mann, 2006; Inamorato et al., 1993; Rains & Poceta, 2006). Specifically, odds ratios of having
insomnia for a migraineur versus nonmigraineur have been reported as 2.1 (Ohayon, 2004), 2.9
(Rasmussen, 1993), and 2.5 (Vgontzas et al., 2008).
Insomnia can be precipitated by many factors. These may include substance or stimulant
use, a comorbid anxiety or mood disorder, pain or another medical condition, being in an
environment that is not conducive to sleep, or by engaging in behaviors that are not conducive to
sleep (Calhoun et al., 2006). Most of these environmental factors and behaviors that are not
conducive to sleep can be classified as inadequate sleep hygiene.
Inadequate Sleep Hygiene
Inadequate sleep hygiene (ISH) is defined in the ICSD-R (AASM, 2001) as a “sleep
disorder due to the performance of daily living activities that are inconsistent with the
maintenance of good quality sleep and full daytime alertness” (AASM, 2001, p. 73). The newest
version of the ICSD, the ICSD-2 (AASM, 2005), describes ISH as one of eleven disorders that
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contributes to insomnia. At least one of the following behaviors must be present in order qualify
for a diagnosis of ISH (however, many are often present):
1) Daytime napping at least two times each week, 2) variable wake-up times or bedtimes,
3) frequent periods (two to three times per week) of extended amounts of time spent in
bed, 4) routine use of products containing alcohol, tobacco, or caffeine in the period
preceding bedtime, 5) scheduling exercise too close to bedtime, 6) engaging in exciting
or emotionally upsetting activities too close to bedtime, 7) frequent use of the bed for
non-sleep-related activities (e.g., television watching, reading, studying, snacking, etc.),
8) sleeping on an uncomfortable bed (poor mattress, inadequate blankets, etc.), 9)
allowing the bedroom to be too bright, too stuffy, too cluttered, too hot, too cold, or in
some way not conducive to sleep, 10) performing activities demanding high levels of
concentration shortly before bed, or 11) allowing mental activities, such as thinking,
planning, reminiscing, etc., to occur in bed (AASM, 2001, p. 76).
Complaints of insomnia or excessive sleepiness, or abnormal polysomnography findings,
are also required to receive a formal diagnosis of ISH. ISH is present in approximately 2% of the
general population and in 5-10% of sleep clinic samples (AASM, 2005).
Many of the aforementioned behaviors disturb sleep (Riedel, 2000; Stepanski & Wyatt,
2003) and there is a significant association between poor global sleep hygiene and poor sleep
quality (Brown, Buboltz, & Soper, 2002; Gallasch & Gradisar, 2007; Lacks & Rotert, 1986;
Mastin, Bryson, & Corwyn, 2006). For example, Brown et al. (2002) found that variable sleep
schedules, going to bed thirsty, environmental noise, and worrying while falling asleep
contributed most to reported poor sleep quality. Other studies have reported similar findings
(Jefferson et al., 2005; Yang, Lin, Hsu, & Cheng, 2010). Inadequate sleep hygiene is sometimes
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hard to identify because it is often confused with environmental sleep disorder (because of
symptom overlap) (AASM, 2005) or is often ignored as a cause for the primary diagnosis of
insomnia (Buysse et al., 1994). A DSM-IV (APA, 1994) field trial conducted by the American
Psychological Association/National Institute of Mental Health showed that only 6.2% of patients
in sleep clinics with a presenting complaint of insomnia were given a primary diagnosis of ISH
(Buysse et al., 1994). However, when secondary diagnoses were included, 34.2% of the patients
held a diagnosis of ISH. 	
  
Research is relatively consistent, however, in finding that ISH behaviors (regardless of
formal diagnosis) are associated with poor sleep. An early survey using the Sleep Hygiene
Awareness and Practice Scale (Lacks & Rotert, 1986) found that insomnia patients engaged in
more unhealthy sleep habits than those who slept well (Lacks & Rotert, 1986). A more recent
study using the same scale reported similar results, with poorer sleep hygiene practices in both
primary insomnia patients and those with insomnia-like symptoms resulting from a
psychological disorder (Kohn & Espie, 2005). Another study compared insomnia patients with
non-insomnia controls and found that insomniacs engaged in more maladaptive sleep hygiene
practices, including cigarette smoking, alcohol use, napping, and having more variable sleepwake schedules (Jefferson et al., 2005). In another study (Yang et al., 2010), arousal-related
behaviors such as watching TV in bed, worrying before going to sleep, or doing important work
before bedtime were found to be significantly different between insomniacs and controls. Taken
together, these studies suggest that poor sleep hygiene is a significant factor in insomnia and
related sleep complaints, even though ISH often remains undiagnosed in individuals who suffer
from insomnia (Gellis & Lichstein, 2009).	
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Sleep Hygiene Treatment
Good sleep hygiene may be described as practicing behaviors that facilitate sleep and
avoiding behaviors that interfere with sleep. Sleep hygiene is usually assessed by the self-report
of nighttime behaviors and environmental variables thought to be nonconducive to sleep. Testretest reliability analysis analyses suggest that these sleep hygiene behaviors are relatively stable
over time (Mastin et al., 2006). A study by Brown et al. (2002) surveyed university students and
found that the practice of proper sleep habits was related positively to good sleep quality,
confirming that sleep hygiene behaviors are valid predictors of other important sleep-related
variables. Because of their importance in sleep disorders, modifying sleep hygiene behaviors has
become an integral part of interventions designed to improve sleep. Hauri first introduced sleep
hygiene as a treatment for insomnia in 1977. Today, sleep hygiene treatment is often subsumed
as a component of other behavioral sleep interventions such as stimulus control therapy, sleep
hygiene education, or behavioral sleep modification (Calhoun & Ford, 2007; Edinger et al.,
2009; Morin et al., 2006). Although the treatment strategies have evolved over the years and
sometimes vary from study to study, the underlying principles are the same. The basic principles
involve psychoeducation about the role of behavior in sleep, training in basic behavioral
strategies to facilitate sleep, training in environmental modification, and instructions to selfmonitor and practice these behaviors on a daily basis (Calhoun & Ford, 2007; Edinger et al.,
2009; Morin et al., 2006; Vincent & Lewycky, 2009). Sample sleep hygiene strategies might
include avoiding caffeine and alcohol in the evening, avoiding daytime naps, avoiding large
meals prior to bedtime, and arranging a sleep environment that is conducive to sleep (e.g., not
too hot or cold).
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A study by Vincent and Lewycky (2009) found that sleep hygiene and stimulus control
therapy were effective treatments for insomnia. In fact, a review by Morin et al. (2006) included
stimulus control therapy and cognitive behavioral therapy (CBT; with sleep hygiene as a major
component) as empirically supported treatments for insomnia. Like CBT, most other insomnia
treatment programs have incorporated sleep hygiene as one facet of a multicomponent approach
to treatment that typically includes relaxation training, cognitive therapy, stimulus control, and/or
sleep restriction therapy (Morin et al., 2006). A study by Scholcket, Bertelson, and Lacks (1988)
evaluated meditation, stimulus control therapy, and sleep hygiene as treatments for insomnia.
They found that sleep hygiene was effective in treating insomnia, as were the other treatments,
but this study had no control group for comparison. Friedman et al. (2000) compared sleep
hygiene to other behavioral sleep interventions and found that sleep hygiene treatment alone was
just as effective as combined sleep hygiene/sleep restriction therapy and combined nap
modification (of sleep restriction therapy)/sleep hygiene. On the other hand, a study by Edinger
et al. (2009) showed that sleep hygiene was not as effective as CBT at treating insomnia, the
latter which included sleep hygiene education and stimulus control therapy in combination with
sleep restriction. These studies in combination suggest that sleep hygiene, often as part of a
larger treatment module, is effective in treating insomnia.
Sleep Hygiene in Migraineurs
Despite the role of insomnia and sleep disorders in migraine (both as triggers and
comorbidities), the utility of using sleep hygiene interventions to reduce migraine has been
explored only recently. In one of the only migraine-specific studies to date, Calhoun and Ford
(2007) hypothesized that behavioral sleep modification (BSM) would be associated with
improvement in headache frequency and intensity in a group of treatment-seeking females with
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chronic migraine. They randomly assigned 43 women to receive either one session of BSM
instructions or one session of ‘sham’ instructions. BSM consisted of providing participants a set
of five sleep hygiene instructions including: 1) scheduling a consistent bedtime allowing eight
hours in bed, 2) eliminating TV watching, reading, and music in bed, 3) using visualization
techniques prior to sleep, 4) eating dinner at least four hours prior to bed and limiting fluids
within two hours of bedtime, and 5) discontinuing naps. All participants received usual medical
care in addition to either the behavioral intervention or the sham/placebo intervention.
Compared to the placebo group, the BSM group experienced significantly greater
reductions in headache frequency and intensity at six-week follow-up. Thirty-five percent of
chronic migraineurs reverted to episodic migraine within this time period, compared to none of
the patients in the placebo group. Once the blind was broken and participants were followed for
another six weeks, 48% had reverted to episodic migraine. Compliance with the BSM
intervention was positively correlated with improvement, such that participants adhering to all
five instructions reported the most improvement. On the other hand, participants who adhered to
less than three instructions did not see a significant reduction in headache frequency or intensity.
This study showed that a brief behavioral intervention including sleep hygiene	
  is effective in
reducing the frequency and intensity of migraine among those with chronic migraine. Another
study by Bruni, Galli, and Guidetti (1999) also found sleep hygiene modification effective at
reducing migraine frequency and duration among children and adolescents with migraine, but the
specific treatment instructions were not clearly outlined in the publication of this study. 	
  
Whereas other studies (Gellis & Lichstein, 2009; Jefferson et al. 2005) have examined
specific sleep behaviors characteristic of insomniacs, research on the specific sleep behaviors
common to migraineurs is sparse. Only one study has examined sleep behaviors common to
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adult migraineurs. Calhoun et al. (2006) surveyed females with transformed (chronic) migraine
presenting to a headache center. They found that chronic migraineurs consistently engaged in a
number of maladaptive sleep behaviors, such as watching TV or reading in bed (78.9%), nocturia
(70.1%; i.e., due to eating or drinking prior to bedtime), taking naps (63.3%), and spending too
much (≥ 9.5 hours; 18.5%) or too little (≤ 6.5 hours; 18.5%) time in bed. Further, a significant
minority reported drinking alcohol during the week (0-1 drinks per week, 79.5%; 2-4 drinks,
15.6%). However, this study did not contain a migraine-free control group for comparison and
did not consider sleeping to relieve migraine as napping. This study also did not include men or
individuals with episodic migraine. Another study by Bruni et al. (1997, 1999) examined specific
sleep behaviors in children and adolescent migraineurs. They found that the migraine
participants consistently fell asleep later (after 11 p.m.- 16.0% v. 7.0%, p < .001), woke up later
(after 8 a.m.- 3.5% v. 0.2%, p < .0001), napped more during the day (7.4% v. 3.3%, p < .005),
and had a more varied bedtime (10.6% v. 5.8%, p < .05) and waking time (9.2% v. 1.7%, p <
.0001) than did the nonmigraineurs. This study selected and treated only the most sleep-disturbed
migraineurs and used only some of the AASM (2001, 2005) criteria to characterize poor sleep
hygiene. The criteria included: bedtime later than 11 p.m., waking time later than 8 a.m., napping
during the day, irregular schedule (bedtime and wake time varying by more than one hour on
school days), caffeine in the late afternoon or evening, and the need to drink fluids or take drugs
to facilitate sleep. The study required that at least two of these criteria be met in order to be
characterized as poor sleep hygiene. Thus, while the existing literature has provided some
preliminary evidence that modifying sleep hygiene behaviors is effective in reducing migraine
frequency, evidence is lacking regarding which specific sleep hygiene behaviors are common
and problematic among adult episodic migraineurs in community samples.
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Goals and Hypotheses of the Present Study
The aims of the present study were to identify the specific maladaptive sleep behaviors
that distinguish migraineurs from individuals without migraine, assess relations between sleep
hygiene and migraine variables, and assess the roles of depression and anxiety in sleep hygiene
practices. Unlike the Calhoun et al. (2006) study that lacked a control group, the current study
used individuals without migraine as a control group. The current study also included men and
individuals with episodic migraine. College students served as participants in the current study in
order to elucidate the relationship between migraine and specific problematic sleep behaviors in
a non-treatment-seeking community sample.
College students were recruited as participants due to their inconsistent sleep patterns and
maladaptive sleep behaviors, and because there is a paucity of research in this area despite the
high prevalence of both sleep problems and migraine among college students. Approximately
25% of college students suffer from migraine (Bigal, Bigal, Betti, Bordini, & Speciali, 2001),
and the prevalence of migraine rises dramatically during the college years (late teens to midtwenties; Lipton, Bigal, Hamelsky, & Scher, 2008). Further, at least two-thirds of college
students report occasional sleep disturbances, and about one-third of these report severe sleep
difficulties (Coren, 1994; Lack, 1986). The large majority of college students have moderate to
severe sleep complaints, and only 11% of students report good sleep quality (Brown et al., 2002;
Buboltz, Brown, & Soper, 2001). Because of the high prevalence of sleep problems among
college students, their use as a sample for this study is of particular relevance. College life likely
contributes to maladaptive sleep patterns, which in turn places students at risk for onset of
migraine and subsequent disability (Brown et al., 2002; Rains & Poceta, 2006). In essence, the
sleep disturbances that occur during the college years may function as etiological factors in the
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subsequent development of migraine. The present study thus endeavored to identify problematic
sleep behaviors and their association with migraine so as to inform the development and
refinement of subsequent behavioral sleep interventions to reduce migraine frequency, intensity,
and disability.
The following specific goals and hypotheses were proposed:
Study Goal 1: To determine if migraineurs engage in poorer sleep hygiene than do
nonmigraineurs.
Hypothesis 1a: Poor sleep hygiene will differentiate migraineurs from controls.
Hypothesis 1b: Migraineurs will engage in poorer sleep hygiene than nonmigraineurs
even after controlling for comorbid depression/anxiety and/or insomnia symptoms.
Study Goal 2: To identify specific patterns of problematic sleep hygiene behaviors that
characterize migraineurs.
Hypothesis 2: Migraineurs will differ from controls on specific sleep hygiene behaviors
(e.g., not having a consistent sleep/wake schedule, more frequent napping, spending more
time in bed, and going to bed physically or emotionally aroused).
Study Goal 3: To determine if migraineurs’ poor sleep hygiene is predictive of migraine-related
variables.
Hypothesis 3: The severity of poor sleep hygiene will be a significant predictor of
migraine frequency, migraine severity, and migraine-related disability.
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Methods
Participants
Participants were undergraduate students at the University of Mississippi who received
modest course credit for their participation. Participants included those who suffered from
migraine headaches and healthy controls who did not suffer from any type of primary headache
other than episodic tension-type headache. Participants who screened positive for migraine were
administered a structured headache interview to confirm the migraine diagnosis. Those verified
as migraineurs comprised the migraine group. Controls were those who denied experiencing
problematic headaches. Assuming a small to moderate effect size (f2 = 0.08), a power level of
0.80, and an alpha level of 0.05, a total sample size of 236 participants was required.
Measures
Demographic Questionnaire. The Demographic Questionnaire consisted of a number of
questions that assess for basic information such as age and gender, and other more specific
questions related to general disability and other headache/migraine variables and symptoms. This
questionnaire can be found in Appendix A.
ID Migraine. The ID Migraine (Lipton et al., 2003) is a three-item self-administered
measure used to screen for migraine in the primary care setting. The three items assess for
migraine-related disability and the symptoms of nausea and light sensitivity, which are uniquely
characteristic of migraine. The endorsement of two or more items is considered a positive screen
for migraine (Lipton et al., 2003). The ID Migraine is one of the briefest but most valid and
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reliable screeners of migraine currently used in research. Construct validity of ID Migraine
scores was established in the original study by comparing positive screens on the measure to
migraine diagnoses made by headache specialists in a large primary care setting (Lipton et al.,
2003). Validity of ID Migraine scores was further established in a separate study by comparing
the measure to the Brief Headache Screen (Maizels & Houle, 2007). The two measures showed
82.6% agreement (kappa = 0.79). Criterion validity of the measure was also established in the
original study. The final three items (out of nine original diagnostic screening questions) showed
a sensitivity of 0.81 and a specificity of 0.75 (positive predictive value = 0.93). Test-retest
reliability was also high (kappa = 0.68; Lipton et al., 2003). This measure can be found in
Appendix B.
Brief Headache Screen. The Brief Headache Screen (BHS; Maizels & Burchette, 2003)
is a seven-item measure that was designed to screen for migraine and drug-rebound headache, as
well as assess for satisfaction with current medication and desire for preventative medication.
The diagnostic portion of the BHS consists of three questions specifically assessing the
frequency of severe (disabling) headache, mild headache, and medication use. A score of 1-3 on
the first and second items signifies episodic migraine. Four of the seven questions require the
rater to rate each item on a four point Likert-type scale (0 = almost never, 4 = daily or near
daily), while the other three questions require a yes or no response. As mentioned above, BHS
scores showed high reliability and validity when compared to the ID Migraine (Maizels &
Houle, 2007) and in the original study (93% specificity for migraine based on responses to
Question 1; Maizels & Burchette, 2003). This measure can be found in Appendix C.
Sleep Hygiene Index. The Sleep Hygiene Index (SHI; Mastin et al., 2006) is a 13-item
self-report measure used to assess the presence of behaviors that comprise the criteria for ISH as
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classified by the ICSD-R (AASM, 2001). The SHI assesses how frequently the respondent
engages in specific sleep behaviors, using a five point Likert-type scale ranging from always to
never. Scores range from 13-65 with higher summed scores on the index indicating more
maladaptive sleep behaviors. SHI scores have adequate test-retest reliability (r = 0.71) and
internal consistency (α = 0.66) that is superior to that of scores of previously published sleep
hygiene instruments (Mastin et al., 2006). SHI scores have shown good validity as evidenced by
significant correlations (p < .01) with the Epworth Sleepiness Scale (r = 0.244; Johns, 1991) and
the Pittsburgh Sleep Quality Index (r = 0.481; Buysse, Reynolds, Monk, Berman, & Kupfer,
1988), indices that have shown to be related to the construct of sleep hygiene (Mastin, Peszka,
Poling, Phillips, & Duke, 2005). The current study examined both the total SHI score as well as
group differences on individual sleep behaviors (items). This measure can be found in Appendix
D.
Migraine Disability Assessment Questionnaire. The Migraine Disability Assessment
Questionnaire (MIDAS; Stewart, Lipton, Dowson, & Sawyer, 2001) is a seven-item measure that
assesses headache-related disability. The MIDAS requires the migraine sufferer to answer five
questions, counting the number of days in the past three months that migraine has limited his/her
activities at school/work, at home, and in social activities. The first five items are summed,
resulting in a global disability score with scores 0-5 indicating little or no disability, 6-10
indicating mild disability, 11-20 indicating moderate disability, and ≥ 21 indicating severe
disability. The final two questions on the measure ask the individual to notate the frequency and
intensity of his/her headaches. The internal consistency, test–retest reliability, and validity of
MIDAS scores have been established in many different populations (α = 0.73-0.76; Stewart et
al., 1999; Stewart, Lipton, & Sawyer, 1999). Validity of MIDAS scores was also established by
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comparing the measure to a 90-day headache diary in migraineurs (Stewart et al., 2000) and by
comparing the measure in migraineurs and controls (Bigal, Rapoport, Lipton, Tepper, & Sheftell,
2003). This measure can be found in Appendix E.
Headache Impact Test-6. The Headache Impact Test-6 (HIT-6; Kosinski et al., 2003) is
a six-item self-report measure of headache-related disability. This measure requires the
individual to rate each item on a five point Likert-type scale from never to always. Scores range
from 36-78, with ≤ 49 characterized as little to no impact on life, 50-55 as some impact, 56-59 as
substantial impact, and ≥ 60 as severe impact. HIT-6 scores have shown to be a reliable and valid
measure of headache-related disability in the general population (with internal consistency =
0.89, alternate forms reliability = 0.90, and test-retest reliability = 0.80; Kosinski et al., 2003)
and in treatment-seeking individuals (α = 0.87; Kawata et al., 2005). This measure can be found
in Appendix F.
Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI; Buysse et
al., 1988) is a 24-item measure that assesses sleep disturbance on seven dimensions: subjective
sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of
sleep medication, and daytime dysfunction (Buysse et al., 1988). Scores from these seven areas
are summed resulting in a global score ranging from 0-21. Internal homogeneity, internal
consistency, and test-retest reliability were established in the original study by Buysse et al.
(1988) in a clinical sample of individuals with depression and sleep disorders. They found that
global PSQI scores > 5 showed 89.6% sensitivity and 86.5% specificity for detecting “good” and
“poor” sleepers. These statistics have since been replicated in a non-clinical sample of adults
(Grandner, Kripke, Yoon, & Youngstedt, 2006) and insomniacs (sensitivity of 98.7, specificity
of 84.4, and α = 0.85; Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002). This
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measure can be found in Appendix G.
Epworth Sleepiness Scale. The Epworth Sleepiness Scale (ESS; Johns, 1991) is a selfadministered eight-item measure of daytime sleepiness in adults. Respondents rate items
pertaining to the likelihood of dozing during various activities on a four point Likert-type scale,
ranging from 0 (would never doze) to 3 (high chance of dozing). Ratings on the ESS are summed
with a score < 10 considered normal (although < 5 is desirable), 10-15 considered as moderate
sleepiness, and 16-24 as severe sleepiness. The ESS is one of the most widely used paper-pencil
measures of daytime sleepiness in adults (Rains & Poceta, 2006) and has been validated against
polysomnographic recordings of an individual’s tendency to fall asleep (Johns, 1991). Reliability
and internal consistency of ESS scores also has been established in a study comparing healthy
medical students to individuals with obstructive sleep apnea (α = 0.88) (Johns, 1992). This
measure can be found in Appendix H.	
  
Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9; Spitzer,
Kroenke, & Williams, 1999) is a self-administered measure of depression that is commonly used
for the purpose of screening for depression among medical patients (Kroenke, Spitzer, &
Williams, 2001). The PHQ-9 assesses the nine diagnostic criteria for a major depressive episode
according to the Diagnostic and Statistical Manual of Mental Disorders (APA, 2000). Scores
range from 0-27 with scores of 5, 10, 15, and 20 reflecting mild, moderate, moderately severe,
and severe depression, respectively. The PHQ-9 is one of the most commonly used and validated
brief measures of depression in use today among medical patients (Fann et al., 2005; Huang,
Chung, Kroenke, Delucchi, & Spitzer, 2006; Kroenke & Spitzer, 2002; Lowe, Kroenke, Herzog,
& Grafe, 2004; Martin, Rief, Klaiberg, & Braehler, 2006; Pinto-Meza, Serrano-Blanco,
Penarrubia, Blanco, & Haro, 2005) and has strong psychometric properties. Construct validity

20	
  

	
  
was established by comparing the PHQ-9 to the 20-item Short-Form General Health Survey,
self-reported sick days and doctor’s visits, and symptom-related disability (Spitzer, William, &
Kroenke, 2000). Criterion validity was established by comparing the PHQ-9 against an
independently structured mental health professional interview in a sample of 580 people
(Kroenke et al., 2001). Specifically, a PHQ-9 score ≥ 10 was shown to have a sensitivity of 88%
and a specificity of 88% for identifying major depression (Kroenke et al., 2001). This measure
can be found in Appendix I.
GAD-7. The GAD-7 (Spitzer, Kroenke, Williams, & Lowe, 2006) is a self-report
measure used to screen for Generalized Anxiety Disorder (GAD). The GAD-7 consists of seven
items that reflect the DSM-IV-TR (APA, 2000) diagnostic criteria for Generalized Anxiety
Disorder. Each item requires the respondent to indicate the frequency of each symptom over the
past two weeks. Each item is rated on a 4-point Likert-type scale ranging from 0 (not at all) to 3
(nearly every day). GAD-7 scores range from 0-21 with scores ≥ 5 indicating mild anxiety,
scores ≥ 10 indicating moderate anxiety, and scores ≥ 15 indicating severe anxiety (Spitzer et al.,
2006).
The GAD-7 is one of the most commonly used, easily accessible, and validated brief
measures of anxiety used in medical research today (Hallgren & Morton, 2007; Lowe et al.,
2008). Initial use of the measure by Spitzer et al. (2006) showed that GAD-7 scores had excellent
internal consistency (α = 0.92), test-retest (procedural) reliability (intraclass correlation = 0.83),
good reliability and good criterion, construct, factorial, and procedural validity in primary care
patients. Scores ≥ 10 also showed high sensitivity (89%) and specificity (82%) for diagnosing
GAD (Spitzer et al., 2006). GAD-7 scores were also shown to be reliable and valid in a study of
more than 5000 subjects in the general population (Lowe et al., 2008). Most recently, the GAD-7
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has also been shown to be effective at detecting other anxiety disorders such as panic disorder,
social phobia, and posttraumatic stress disorder (Kroenke, Spitzer, Williams, Monahan, & Lowe,
2007). This measure can be found in Appendix J.
Structured Diagnostic Interview for Headache – Revised (Brief Version). The
Structured Diagnostic Interview for Headache-Revised (SDIH-R; Penzien, Bartley, Rhudy, &
Rains, 2007) consists of 17 questions assessing migraine and contains appendices for assessing
aura symptoms, cluster headache symptoms, medication over-use symptoms, and post-traumatic
headache symptoms. The majority of questions assess migraine pain location, headache intensity,
pain features, frequency, history, duration, and other migraine symptoms. Responses to this
interview allow for determination of a migraine diagnosis based on criteria of the ICHD-II (IHS,
2004). In the current study, migraine participants were defined as those who met ICHD-II
diagnostic criteria for migraine (ICHD code 1.1), typical migraine with aura (1.2.1), or chronic
migraine (1.5.1). This measure can be found in Appendix K.
Procedures
After providing written informed consent, participants completed a packet of
questionnaires including the aforementioned measures. Those who screened positive for
migraine based on their responses to the ID-Migraine were scheduled to meet individually with a
trained headache researcher for administration of the SDIH-R, in order to confirm their
diagnostic status. Those who met diagnostic criteria for migraine were assigned to the migraine
group. Those denying problematic headaches on the demographic questionnaire, ID-Migraine,
and Brief Headache Screen comprised the control group and were not administered the SDIH-R.
Participants who screened positive for migraine on the ID-Migraine but did not meet diagnostic
criteria for migraine based on the structured interview were assigned to the control group.
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(Although not a specific focus of this thesis, individuals who met diagnostic criteria for migraine
were asked to engage in two weeks of self-monitoring of their sleep behaviors and migraine
patterns as part of an ancillary study. Participants also completed a computerized pain attentional
bias task as part of another ancillary study.)
Statistical Analyses
In order to test the main hypothesis, which sought to examine whether episodic
migraineurs and controls differed on a global score of sleep hygiene, an independent samples ttest was conducted. Subsequently, a series of univariate ANCOVAs were used to determine if
the significant difference in global sleep hygiene persisted after individually controlling for
symptoms of depression (PHQ-9), anxiety (GAD-7), and insomnia (PSQI and ESS). A
MANOVA was conducted in order to test the second hypothesis, which sought to compare the
groups on specific sleep hygiene behaviors as indexed by the 13 SHI items while controlling for
family-wise Type I error rates given the number of dependent variables assessed. Univariate
follow-up ANOVAs of individual items were conducted as appropriate. In addition to examining
specific sleep hygiene behaviors, the current study also sought to predict migraine frequency,
severity, and headache-related disability using global sleep hygiene scores. Linear regression
analyses were conducted in order to determine the amount of variance predicted by global sleep
hygiene in these migraine variables. To further explore psychological symptoms comorbid with
migraine and sleep disturbance, a MANOVA was performed to determine if the groups differed
on insomnia, anxiety, and depression, with follow-up univariate ANOVAs as appropriate.
Finally, a chi-square analysis was conducted in order to determine if there were any clinically
significant differences between groups on proportions with elevated scores on each
psychological variable.

23	
  

	
  

Results
Participant Demographics and Migraine Prevalence
The sample consisted of 323 college students (70.9% female) with a mean age of 19.28
years (SD = 3.38). The majority (62.8%) of the sample was Caucasian, 29.1% was African
American, 3.1% was Asian, 0.9% was Hispanic/Latino, 1.2% was Native American/Pacific
Islander, and 2.8% were of other ethnicities. With regard to migraine, 92 participants (28.5%)
met ICHD-II diagnostic criteria for migraine: 84 (26%) with episodic migraine and eight (2.5%)
with chronic migraine. Because the present study focused on episodic migraine, chronic
migraineurs were excluded from subsequent analyses. Nearly three-quarters (73.8%) of episodic
migraineurs were female, and 27.4% experienced aura. Average headache frequency for episodic
migraineurs was 5.11 days/month (SD = 3.80). They reported an average headache-related
disability score of 17.07 (SD = 19.15) on the MIDAS and an average score of 60.89 (SD = 5.09)
on the HIT-6. Although half were classified as having minimal or mild migraine-related
disability, 53% of episodic migraineurs endorsed moderate to severe disability on the MIDAS,
compared to 84.3% endorsing substantial to severe impact on the HIT-6.
Data Analytic Assumptions
Histograms, Q-Q plots, and descriptive statistics data (i.e., skewness, kurtosis) were used
to assess data analytic assumptions for the main total scores of interest (SHI, ESS, PSQI, PHQ-9,
GAD-7) to be compared between episodic migraineurs and controls and found satisfactory.
Levene’s test of equality of error variances confirmed that homogeneity of variance was met for
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all main criterion variables. Episodic migraineurs and control participants were then assessed for
multivariate outliers on the main total scores of interest by group using Mahalanobis distance;
one multivariate outlier was found using a conservative p < .001 cutoff (control participant) and
was thus removed from subsequent analyses.
Sleep Hygiene and Its Associations
Regarding sleep hygiene, over half of the entire sample (episodic migraineurs and
controls) endorsed frequently or always engaging in poor sleep hygiene behaviors such as going
to bed at different times each day (56.7%); doing something mentally stimulating before bedtime
(58.9%); using the bed for things other than sleep and sex (61.8%); doing important work before
bedtime (56.5%); and thinking, planning, or worrying when in bed (56.7%) (see Table 1).
Episodic migraineurs obtained significantly higher total scores on the SHI than controls (M =
38.24 [SD = 6.71] v. 36.54 [SD = 6.06], p < .05), indicating that they evidenced poorer overall
sleep hygiene. After controlling for symptoms of insomnia, anxiety, and depression using
separate ANCOVAs, however, these differences were rendered nonsignificant: PSQI overall
model: F(1,284) = .076, p = .783, partial η2 = .000; ESS overall model: F(1,305) = 2.45, p =
.119, partial η2 = .008; PHQ-9 overall model: F(1,311) = .116, p = .733, partial η2 = .000; GAD7 overall model: F(1,310) = .518, p = .472, partial η2 = .002. Notably, the corresponding
covariate effect size values (η2) ranged from .093 (ESS) to .242 (PHQ-9); the effect size of
insomnia as measured by the PSQI was higher than that of the ESS (.175 vs. .093, respectively).
The overall MANOVA comparing groups on the 13 SHI items was nonsignificant,
F(13,295) = 1.076, p = .379, partial η2 = .045. Although the MANOVA was nonsignificant,
because the overall sleep hygiene score differed significantly between the groups, an ANOVA
was performed on individual items to aid in interpretation. Of all the items, only the variable of

25	
  

	
  
“going to bed feeling stressed, angry, upset, or nervous” differed significantly between groups,
F(1,312) = 6.46; p = .012, partial η2 = .020. However, applying a Bonferroni correction to this
result (requiring a p < .004, given the non-significant MANOVA) would not retain statistical
significance. There was no difference in sleep hygiene between episodic migraineurs with and
without aura (M = 39.00 [SD = 7.08] v. 36.22 [SD = 5.23], p = .09).
Headache-Related Disability
Among episodic migraineurs, linear regression analyses confirmed that poorer sleep
hygiene significantly predicted headache-related disability as measured by both the MIDAS and
HIT-6, accounting for 11.0% and 7.7% of variance in headache disability, respectively (see
Table 2). Despite its relationship with insomnia though, sleep hygiene did not predict migraine
severity or frequency as obtained from SDIH-R responses. Insomnia (as measured by the PSQI),
conversely, significantly predicted headache-related disability as measured by the MIDAS (R2 =
18.2%) and HIT-6 (R2 = 6.8%), as well as migraine frequency (R2 = 14.8%), but not headache
severity. No significant differences emerged between episodic migraineurs with and without aura
in headache-related disability or migraine frequency or severity (see Table 3).
Psychological Variables
Bivariate correlational analyses showed that global sleep hygiene scores were
significantly correlated with psychological variables including insomnia (PSQI: r = .432, p <
.001; ESS: r = .315, p < .001), depression (r = .503, p < .001), and anxiety (r = .447, p < .001)
for the entire sample. In comparing episodic migraineurs and controls on these variables using a
MANOVA, the Wilks’ lambda multivariate criterion for overall group differences was
significant, F(4,276) = 7.756, p < .0001 (partial η2 = .101), indicating that episodic migraine and
nonmigraine participants differed on the combination of variables relevant to the psychological
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impact of migraine. No significant differences emerged between episodic migraineurs with and
without aura on any of the assessed psychological variables (see Table 4). Subsequent univariate
ANOVAs revealed that episodic migraineurs reported statistically higher levels of insomnia (as
measured by the PSQI), depression, and anxiety than did controls (see Table 5). The difference
between daytime sleepiness approached significance, though the majority of participants in both
groups reported clinically significant elevations on this variable (ESS ≥ 10 indicating disordered
sleep) (see Table 6).
Efforts to quantify clinically significant differences involved comparing the proportion of
each group achieving an elevated score on the psychological variables of interest (i.e., PSQI > 5;
ESS, PHQ-9, and GAD-7 ≥ 10). As is evident from Table 6, a large proportion of both groups
endorsed clinically significant problems with sleep pertaining to daytime sleepiness (44.8% of
sample) and insomnia (68.3% of sample), as well as elevated levels of depression (25.5%) and
anxiety (23.0%). However, a significantly higher proportion of migraineurs than controls
achieved clinically significant elevations on insomnia, depression, and anxiety scores. No
differences in daytime sleepiness were observed, consistent with results of nonsignificant
findings on the univariate ANOVA between groups.
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Discussion
The present study sought to identify associations between problematic sleep hygiene
behaviors and episodic migraine so as to inform the development and refinement of subsequent
behavioral sleep interventions to reduce migraine symptomatology. The present study also
explored psychological disorders such as anxiety and depression and their relation to migraine,
sleep hygiene, and insomnia in college students, a population of interest because of their high
rates of migraine (Bigal et al., 2001; Lipton et al., 2008), sleep disturbances (Brown et al., 2002;
Coren, 1994; Lack, 1986), and psychological comorbidities (Kessler et al., 2005; Smitherman,
McDermott, & Buchanan, 2011). Conclusions from the current study are strengthened by the fact
that many of our observations were consistent with previous studies on this population of
interest.
First, the observed prevalence of episodic migraine was consistent with previous studies
on college students. The current study observed a prevalence of 28.5% while both Bigal et al.
(2001) and Smitherman et al. (2011) observed a prevalence approximating 25%. Secondly, the
observed prevalence of sleep disturbance was also consistent with previous studies among this
population (Buboltz et al., 2001). In the current study, 68.3% of the total sample (85.9% of
migraineurs, 61.7% of controls) reported poor sleep quality (PSQI > 5), while 73% of students in
the study by Buboltz et al. endorsed at least occasional sleep problems. More direct comparisons
between these two studies are difficult because different measures of sleep quality were used.
Rates of elevated psychological symptomatology among college migraineurs were generally
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consistent with, though slightly higher than, those observed in previous studies. For instance, in
the current study significant symptoms of depression and anxiety were reported by 39.3% and
34.5% of migraineurs, respectively, compared to 27.2% and 23.9% of migraineurs, respectively
in Smitherman et al. In addition, Kessler et al. (2005) reported the lifetime of prevalence of
experiencing an anxiety or mood disorder between the ages of 18 and 29 to be 21.4%
(depression) and 30.2% (anxiety). Finally, the presence of episodic migraine was associated with
significant headache-related disability for a sizeable proportion of participants, although mean
disability scores were higher than those from previous studies (Smitherman et al.).
Sleep Hygiene
As was the main focus of this study, sleep hygiene was found to be poorer among
migraineurs than controls. This is consistent with previous findings by Calhoun et al. (2006) and
Bruni et al. (1997, 1999) that migraineurs consistently engage in behaviors that are
nonconducive to sleep, such as watching TV or reading in bed (78.9% of migraineurs); eating or
drinking prior to bedtime (70.1%); taking naps (63.3%); spending too much or little time in bed
(37%); and having more variable sleep/wake schedules. Although insomnia symptoms and poor
sleep hygiene were more prevalent in the migraine group, only one sleep hygiene variable, going
to bed feeling stressed, angry, upset, or nervous, was different between the migraine and control
groups. However, because the overall analysis of sleep hygiene items was nonsignificant, and
because this finding was nonsignificant after Bonferroni correction, the single item is likely not
of particular importance in informing the current study. Despite research from previous studies
indicating that both adolescent migraineurs (Bruni et al.) and women with transformed migraine
(Calhoun et al.) exhibit poor sleep hygiene behaviors (e.g., frequent napping, variable sleep/wake
schedules), the current study did not reflect these previously-reported group differences.
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Our adherence to the a priori sample size calculation rules out inadequate sample size as
a contributing factor to the null differences on multiple sleep hygiene components. One
explanation for the present results is that the control group also exhibited poor sleep habits
(Buboltz et al., 2001; Coren, 1994). This argument is supported by the finding that over half of
the student sample endorsed frequently or always going to bed at different times from day to day;
doing something mentally stimulating or important work before bedtime; using the bed for things
other than sleep and sex; and thinking, planning, or worrying in bed. A large proportion of both
groups also endorsed clinically significant sleep problems pertaining to insomnia and daytime
sleepiness, and thus any potential differences might be better elucidated using a control group
with less disturbed sleep. However, another possible explanation for our failure to observe group
differences is that sleep hygiene behaviors are not as important among episodic migraineurs as
they are among chronic migraineurs. Kelman and Rains (2005) found that chronic migraineurs
reported shorter sleep episodes and were more likely to complain of difficulty falling asleep than
were episodic migraineurs. Ohayon (2005) also described a strong relationship between sleep
difficulties and chronic headaches as did Calhoun et al. (2006), who found that 83.7% of chronic
migraineurs stated that they usually awakened tired compared to only 38.1% of episodic
migraineurs. Considering our null findings in conjunction with existing studies of adults with
chronic migraine, the role of poor sleep hygiene does not appear to be as strong among episodic
migraineurs. However, future studies are warranted to confirm this latter hypothesis.
Comorbid Psychological Symptoms
Although migraineurs and controls differed on a score of global sleep hygiene, this
difference was attributable principally to differences in co-occurring symptoms of insomnia,
anxiety, and depression. Consistent with numerous previous studies (Lanteri-Minet et al., 2005;
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Oedegaard et al., 2006; Paiva et al., 1994; Rains & Poceta, 2006; Smitherman et al., 2011),
episodic migraineurs reported greater symptoms of depression, anxiety, and insomnia than did
nonmigraineurs. However, our results are contrary to those of Vgontzas et al. (2008), who found
that sleep disturbance persisted even after controlling for depression and anxiety disorders. The
results of the aforementioned study and the current study likely conflict because Vgontzas et al.
controlled for lifetime and current rates of all anxiety disorders (instead of GAD symptoms
only). They also compared migraineurs and nonmigraineurs on more general sleep complaints,
such as difficulty falling and staying asleep, instead of specific sleep hygiene behaviors, as did
the current study. Again, these findings strengthen the idea that, although closely related (Buysse
et al., 1994), general symptoms of insomnia have a greater influence on migraine and comorbid
psychological disorders than do sleep hygiene behaviors in isolation.
Treatment Implications of the Current Study
Although directly modifying sleep hygiene behaviors has shown promise in treating
chronic migraine (Calhoun & Ford, 2007), sleep hygiene treatment is not usually offered in
isolation for insomnia specifically because its effects on insomnia are less potent than those of
stimulus control and sleep restriction, as confirmed by systematic reviews (Morin et al., 2006),
practice parameters (Morganthaler et al., 2006), and clinical guidelines (Schutte-Rodin et al.,
2008). Another reason that sleep hygiene treatment is not often offered in isolation is because
sleep hygiene only targets specific sleep habits and does not address other factors that contribute
to insomnia (e.g., environmental cue stimuli, psychological comorbidities). As such, broad-based
insomnia treatment packages tend to include modifying sleep behaviors, restricting sleep, and
altering environmental stimuli, as well as directly targeting other psychological symptoms
related to comorbid depression and anxiety.

31	
  

	
  
Based on the current findings that poorer sleep hygiene and insomnia symptoms
significantly predicted migraine-related disability, a rigorous sleep hygiene protocol might
beneficially impact headache-related disability among episodic migraineurs; however, this notion
awaits empirical verification. Although the present study did not find associations between sleep
hygiene and migraine frequency or severity, previous research has indicated that various sleep
disturbances (e.g., hypnic jerks, nightmares) are related to headache severity (Bruni et al., 1999).
In light of this evidence and the potency of more comprehensive sleep interventions, perhaps the
most effective means of improving sleep and migraine is a treatment package that addresses
insomnia symptoms (i.e., sleep restriction, stimulus control), modifies sleep hygiene behaviors,
and manages comorbid psychological symptoms (Edinger et al., 2009; Friedman et al., 2000;
Scholcket et al., 1988; Vincent & Lewycky, 2009).
Limitations and Future Directions
While this study is unique because of its large sample size, focus on episodic
migraineurs, and adherence to ICHD-II diagnostic criteria, limitations exist. One limitation of
this study is that alcohol use/abuse was not assessed, despite the fact that it is often comorbid
with and influences sleep problems (Johnson & Breslau, 2001) and is disproportionately
prevalent among college populations (O’Malley & Johnston, 2002). Another limitation is
reliance on survey-based instruments to assess the sleep and psychological variables. While
adherence to a structured diagnostic headache interview and ICHD-II diagnostic criteria are
strengths of the headache data, daily diary data on sleep and structured interview diagnoses of
affective disorders would have further strengthened the present study. The aforementioned
ancillary study will use self-monitoring data to extend the present findings and test additional
hypotheses related to sleep disturbance and migraine using time-series analyses.
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As mentioned above, studies are needed comparing the role of sleep hygiene (versus
other insomnia variables) in episodic and chronic migraineurs, and in validating the efficacy of
more broad-based sleep interventions among episodic migraineurs with comorbid psychological
disorders. In light of limitations of the present study, future studies should assess relations
between alcohol use and insomnia/sleep hygiene among college migraineurs. Such studies could
use a design similar to the present study but with the addition of prospective self-monitoring data
for alcohol, sleep, and migraine variables and in using interactions between alcohol and sleep to
predict headache occurrence and disability. Given the significant headache-related disability
observed among this sample, broad-based university education and intervention efforts should
focus on identifying college migraineurs with significant headache-related disability and offering
validated pharmacological or behavioral migraine interventions.
Although a large proportion of treatment studies have focused on chronic migraineurs,
outcome studies should explore means of targeting headache-related disability among episodic
migraineurs given their evidenced high rates of functional impairment. Specifically, treatment
studies could focus on assessing and comparing the efficacy of sleep hygiene interventions that
have shown promise with chronic migraineurs (Calhoun & Ford, 2007) with more
comprehensive sleep modification interventions that have strong research support for insomnia
more broadly (e.g., stimulus control and sleep restriction). Although there is evidence for the
efficacy of these treatments, the exact mechanisms of action still remain largely unclear,
particularly as they relate to beneficial impact on migraine symptoms. Dismantling studies are
warranted to determine the most essential therapeutic mechanisms that underlie improvements in
migraine stemming from improvements in sleep. Furthermore, given the paucity of data
regarding the effects of treating comorbid psychological disorders on migraine, a strong need
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remains for treatment studies that assess the effects of treating comorbid depression or anxiety on
both sleep and headache symptoms. Because availability of effective behavioral therapies
remains a barrier to broader treatment access, further research is needed also on promoting
dissemination of empirically-supported behavioral interventions, which are both efficacious
(Rains, Penzien, McCrory, & Gray, 2005) and cost-effective (Schafer et al., 2011) in comparison
to pharmacologic management. Cumulatively, such studies will help further the growing
literature pertaining to the role of sleep and related variables in perpetuating migraine.
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Table 1
Group Differences on Sleep Hygiene Index Items

1. I take daytime
naps lasting two or
more hours.
2. I go to bed at
different times from
day to day.
3. I get out of bed at
different times from
day to day.
4. I exercise to the
point of sweating
within one hour of
bedtime.
5. I stay in bed
longer than I
should two or three
times a week.
6. I use alcohol,
tobacco, or caffeine
within four hours of
going to bed or
after going to bed.
7. I do something
that may wake me
up before bedtime
(e.g., watch TV,
read, eat, or study).
8. I go to bed feeling
stressed, angry,
upset, or nervous.
9. I use my bed for
things other than
sleeping or sex (e.g.,
watch TV, read,
eat, or study).
10. I sleep on an
uncomfortable bed
(e.g., poor mattress
or pillow, too many
or not enough
blankets).
11. I sleep in an

Episodic
Migraineurs
M (SD)

Controls
M (SD)

P
value

% of controls
endorsing
frequently or
always

P value

18.26

% of
migraineurs
endorsing
frequently or
always
25.00

2.75 (1.02)

2.52 (1.07)

.088

3.68 (1.08)

3.57 (1.04)

.443

55.65

59.52

.803

3.02 (1.25)

2.92 (1.10)

.469

30.57

38.10

.254

1.73 (0.87)

1.72 (0.81)

.934

3.49

2.38

.077

2.76 (1.19)

2.49 (1.14)

.064

21.93

26.19

.209

2.37 (1.31)

2.12 (1.14)

.091

14.35

19.05

.083

3.55 (1.12)

3.60 (1.09)

.746

58.26

60.71

.353

3.02 (0.93)

2.71 (0.97)

.012*

19.57

23.81

.010**

3.63 (1.06)

3.57 (1.28)

.830

63.04

58.33

.037*

2.13 (1.19)

2.00 (1.10)

.329

12.17

15.48

.876

2.42 (1.16)

2.19 (1.16)

.150

14.35

21.43

.137
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11. I sleep in an
uncomfortable
bedroom (e.g., too
bright, too stuffy,
too hot, too cold,
too noisy).
12. I do important
work before
bedtime (e.g., pay
bills, schedule, or
study).
13. I think, plan, or
worry when I am in
bed.

2.42 (1.16)

2.19 (1.16)

.150

14.35

21.43

.137

3.55 (0.97)

3.60 (0.96)

.722

57.21

54.76

.987

3.63 (1.08)

3.56 (1.08)

.517

55.65

59.52

.978

* p < .05. ** p < .01
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Table 2
Sleep Hygiene and Insomnia as Predictors of Migraine Variables

	
  
MIDAS	
  

Sleep hygiene as predictor
F value	
  
P value	
  

R2	
  

Insomnia (PSQI) as predictor
F value	
  
P value	
  
R2	
  

10.02	
  

.002**	
  

.110	
  

16.65	
  

.000**	
  

.182	
  

HIT-6	
  

6.71	
  

.011*	
  

.077	
  

5.47	
  

.022*	
  

.068	
  

Severity	
  

1.52	
  

.221	
  

.018	
  

1.41	
  

.239	
  

.018	
  

Frequency	
  

1.00	
  

.320	
  

.013	
  

12.50	
  

.001**	
  

.148	
  

* p < .05. ** p < .01
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Table 3
Differences on Migraine Variables Between Migraineurs With and Without Aura

HIT-6	
  
MIDAS	
  

Migraineurs without aura
M (SD)
N = 61
60.28 (4.59)	
  

Migraineurs with aura
M (SD)
N = 23
62.48 (6.02)	
  

P value
.078	
  

16.50 (19.05)	
  

18.54 (19.78)	
  

.666	
  

Frequency	
  

5.16 (3.95)	
  

4.98 (3.46)	
  

.853	
  

Severity	
  

6.62 (1.40)	
  

7.13 (2.58)	
  

.243	
  

54	
  

	
  
Table 4
Differences on Psychological Variables Between Migraineurs With and Without Aura

PSQI (insomnia)	
  

Migraineurs without aura
M (SD)
N = 61
8.89 (3.65)	
  

Migraineurs with aura
M (SD)
N = 23
8.90 (2.63)	
  

P value
.991	
  

GAD-7 (anxiety)	
  

7.87 (5.05)	
  

7.78 (4.23)	
  

.942	
  

PHQ-9 (depression)	
  

8.46 (5.08)	
  

9.00 (4.63)	
  

.657	
  

10.44 (3.10)	
  

9.30 (4.42)	
  

.192	
  

ESS (insomnia)	
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Table 5
Group Differences on Psychological Variables

Episodic Migraineurs

Controls

M (SD)

M (SD)

ESS (insomnia)

10.12 (3.53)

9.19 (3.79)

3.77

PSQI (insomnia)

8.90 (3.39)

6.60 (3.05)

PHQ-9 (depression)

8.61 (4.94)

GAD-7 (anxiety)

7.85 (4.81)

* p < .05. ** p < .01
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F Value

P Value

partial η 2

.053

.012

30.23

.000**

.096

6.39 (4.57)

13.85

.000**

.043

5.76 (4.75)

11.72

.001**

.036

	
  
Table 6
Percent of Sample Reaching Clinical Significance on Psychological Variables

% of episodic migraineurs

% of controls reaching

P Value

reaching clinical significance

clinical significance

of Chi-square

ESS (insomnia)

54.9

41.2

.287

PSQI (insomnia)

85.9

61.7

.001**

PHQ-9 (depression)

39.3

20.4

.001**

GAD-7 (anxiety)

34.5

18.8

.044*

* p < .05. ** p < .01
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Demographic	
  Questionnaire	
  
Age: ___________
Gender (circle one): Male
Race (circle one):

Female

Caucasian

Transgender

African American

Native American/Pacific Islander

Asian

Hispanic/Latino

Other: ______________

What is your approximate height and weight?

_______ inches

_____ pounds

Do you snore (check one)? _____ Usually

____ Sometimes

_____ No

Have a doctor ever diagnosed you with migraines?

_____Yes

_____No

What year of school are you currently in (circle one)?
Freshman

Sophomore

Junior

Senior

Graduate Student

N/A

In the past 3 months, how many days of school have you missed?
_____ days
In the past 3 months, how many days were you unable to carry on your usual function at home?
_____ days
In the past 3 months, about how many medical visits have you made (include visits to your
regular doctor, specialists, and Urgent Care or Emergency room)?
_____ visits
In the past 3 months, how many days did your health interfere with your ability to study?
_____ days

Have you had one or more problem headaches within the past year (Do NOT count
headaches occurring during a hangover or sinus infection)?
_____Yes

_____No

If YES, how many of these headaches do you have per month, on average?
______ headaches per month
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On average how severe are these headaches (circle one number)?
0
No
Pain

1

2

3

4

Mild
Pain

5
6
Moderate
Pain

7

8
Very
Painful

9

10
Extremely
Painful

Which of the following that are typical features of these headaches (check all that apply)?
_____ Occurs on one side of head
_____ Pulsing/throbbing pain
_____ Nausea or vomiting
_____ Sensitivity to light
_____ Sensitivity to sound
_____ Visual or sensory symptoms that occur BEFORE the headache begins

61	
  

	
  
Appendix B

62	
  

	
  

ID	
  Migraine
Check one answer for each question below.
1.

Has a headache limited your activities for a day or more in the last three months?
_____ Yes

2.

Are you nauseated or sick to your stomach when you have a headache?
_____ Yes

3.

_____ No

_____ No

Does light bother you when you have a headache?
_____ Yes

_____ No

From Lipton et al., 2003, in the public domain.
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Brief Headache Screen
Please answer the following questions about your headaches. Check the best answer for each
question below.
1. How often do you get severe headaches (difficult or unable to continue normal function)?
_____ Daily or near daily
_____ 3-4 days per week
_____ Between 2 days per week and 2 days per month
_____ Once a month or less
_____ Almost never
2. How often do you get mild or less severe headaches?
_____ Daily or near daily
_____ 3-4 days per week
_____ Between 2 days per week and 2 days per month
_____ Once a month or less
_____ Almost never
3. How often do you take pain relievers, or any medication to relieve headache symptoms?
_____ Daily or near daily
_____ 3-4 days per week
_____ Between 2 days per week and 2 days per month
_____ Once a month or less
_____ Almost never
4. How often do you miss some work or leisure time because of headache?
_____ Daily or near daily
_____ 3-4 days per week
_____ Between 2 days per week and 2 days per month
_____ Once a month or less
_____ Almost never
5. Are you satisfied with the current medication you use to relieve your headaches?
_____ Yes

_____ No

6. Are you taking daily prescription medication to prevent headaches?
_____ Yes

_____ No

7. If no, do your headaches trouble you enough to take daily preventive medication?
_____ Yes

_____ No
Maizels & Burchette, 2003. Reprinted with permission.
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Sleep Hygiene Index
Indicate how frequently you engage in each of the following behaviors.
1=Never
2=Rarely
3=Sometimes 4=Frequently 5=Always
1. I take daytime naps lasting two or more hours.
1
2
3

4

5

2. I go to bed at different times from day to day.
1
2
3

4

5

3. I get out of bed at different times from day to day.
1
2
3

4

5

4. I exercise to the point of sweating within 1 hour of going to bed.
1
2
3
4

5

5. I stay in bed longer than I should two or three times a week.
1
2
3
4

5

6. I use alcohol, tobacco, or caffeine within 4 hours of going to bed or after going to bed.
1
2
3
4
5
7. I do something that may wake me up before bedtime (for example: play video games, use the internet,
or clean).
1
2
3
4
5
8. I go to bed feeling stressed, angry, upset, or nervous.
1
2
3
4

5

9. I use my bed for things other than sleeping or sex (for example: watch television, read, eat, or study).
1
2
3
4
5
10. I sleep on an uncomfortable bed (for example: poor mattress or pillow, too much or not enough
blankets).
1
2
3
4
5
11. I sleep in an uncomfortable bedroom (for example: too bright, too stuffy, too hot, too cold, or too
noisy).
1
2
3
4
5
12. I do important work before bedtime (for example: pay bills, schedule, or study).
1
2
3
4
5
13. I think, plan, or worry when I am in bed.
1
2
3

4

5

Mastin, Bryson, & Corwyn, 2006, Reprinted with permission
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MIDAS
Please answer the following questions about ALL your headaches you have had over the
last 3 months. Write in your answer for each question below.
1. On how many days in the last 3 months did you miss work or school because of your
headaches?
__________ days
2. How many days in the last 3 months was your productivity at work or school reduced
by half or more because of your headaches?
(Do not include days you counted in question 1 where you missed work or school.)
__________ days
3. On how many days in the last 3 months did you NOT do household work because of
your headaches?
__________ days
4. How many days in the last 3 months was your productivity in household work
reduced by half of more because of your headaches?
(Do not include days you counted in question 3 where you did not do household work.)
__________ days
5. On how many days in the last 3 months did you miss family, social or leisure
activities because of your headaches?
__________ days
6. On how many days in the last 3 months did you have any headache?
(If a headache lasted more than 1 day, count each day)
__________ days
7. On a scale of 0 - 10, on average how painful were these headaches?
(where 0 = no pain at all and 10 = pain as bad as it can be)
__________ days
Lipton et al., 2003, and Stewart et al., 1999, 2003, Reprinted with permission
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HIT-6
This questionnaire was designed to help you describe and communicate the way you feel
and what you cannot do because of headaches.
To complete, please circle one answer for each question.
1) When you have headaches, how often is the pain severe?
Never

Rarely

Sometimes

Very

Often

Always

2) How often do headaches limit your ability to do usual daily activities including household
work, work, school, or social activities?
Never

Rarely

Sometimes

Very

Often

Always

3) When you have a headache, how often do you wish you could lie down?
Never

Rarely

Sometimes

Very

Often

Always

4) In the past 4 weeks, how often have you felt too tired to do work or daily activities because of
your headaches?
Never

Rarely

Sometimes

Very

Often

Always

5) In the past 4 weeks, how often have you felt fed up or irritated because of your headaches?
Never

Rarely

Sometimes

Very

Often

Always

6) In the past 4 weeks, how often did headaches limit your ability to concentrate on work or daily
activities?
Never

Rarely

Sometimes

Very

Often

From Kosinski et al., 2003, in the public domain.
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Name:__________________________________________

Date: ________________

Pittsburgh Sleep Quality Index (PSQI)

Instructions: The following questions relate to your usual sleep habits during the past month only. Your answers
should indicate the most accurate reply for the majority of days and nights in the past month. Please answer
all questions.
1. During the past month, what time have you usually gone to bed at night? ___________________
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each night? __________
3. During the past month, what time have you usually gotten up in the morning? ___________________
4. During the past month, how many hours of actual sleep did you get at night? (This may be different than the
number of hours you spent in bed.) ___________________
5. During the past month, how often have you had
trouble sleeping because you…

Not during
the past
month

Less than
once a
week

Once or
twice a
week

Three or more
times a week

No
problem
at all

Only a
very slight
problem

Somewhat
of a
problem

A very big
problem

Very
good

Fairly
good

Fairly
bad

Very
bad

a. Cannot get to sleep within 30 minutes
b. Wake up in the middle of the night or early
morning
c. Have to get up to use the bathroom
d. Cannot breathe comfortably
e. Cough or snore loudly
f. Feel too cold
g. Feel too hot
h. Have bad dreams
i. Have pain
j. Other reason(s), please describe:

6. During the past month, how often have you
taken medicine to help you sleep (prescribed or
“over the counter”)?
7. During the past month, how often have you had
trouble staying awake while driving, eating meals,
or engaging in social activity?

8. During the past month, how much of a problem
has it been for you to keep up enough enthusiasm
to get things done?

9. During the past month, how would you rate
your sleep quality overall?

From Buysse et al., 1988, in the public domain.
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Epworth Sleepiness Scale
How likely are you to doze off or fall asleep in the following situations, in contrast to just feeling
tired?
These questions are about your usual way of life in recent times. Even if you have not
done some of these things recently, try to work out how they would have affected you.
Use the following scale to choose the most appropriate number for each situation:
0 - Would never doze
1 - Slight chance of dozing
2 - Moderate chance of dozing
3 - High chance of dozing
Activity & Chance of Dozing
Sitting and reading
Watching TV
Sitting inactive in a public place (meeting, theater, etc)
As a passenger in a car for 1 hour without a break
Lying down in the afternoon when circumstances permit
Sitting and talking to someone
Sitting quietly after lunch without alcohol
In a car, while stopped for a few minutes in traffic

_____
_____
_____
_____
_____
_____
_____
_____

Total _____

Epworth sleepiness scale. Each question is answered with a number from 0 (not at all
likely to fall asleep) to 3 (very likely to fall asleep). This yields a total of 0 (minimum) to
24 (maximum). Scores above 10 warrant investigation.
SOURCE: JOHNS MW. A NEW METHOD OF MEASURING SLEEPINESS: THE EPWORTH
SLEEPINESS SCALE. SLEEP 1991; 14:540-54

From Johns, 1991, in the public domain.
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PHQ-9
Over the last two weeks, how often have you been bothered by any of the following problems:
(circle the number that applies to you)
More
Several
Nearly
Not at
than
all
days
half the every day
days
1. Little interest or pleasure in doing things
0
1
2
3
2. Feeling down, depressed, or hopeless

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

Not
difficult
at all

Somewhat
difficult

Very
difficult

Extremely
Difficult

3. Trouble falling or staying asleep, or
sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself—or that you
are a failure or have let yourself or your
family down
7. Trouble concentrating on things, such as
reading the newspaper or watching
television
8. Moving or speaking so slowly that other
people could have noticed. Or the
opposite—being so fidgety or restless that
you have been moving around a lot more
than usual
9. Thoughts that you would be better off
dead, or of hurting yourself in some way
If you checked off any problems, how
difficult have these problems made it for
you to do your work, take care of things at
home, or get along with other people?
Total (For health professionals only) =
_____

PHQ-9 is adapted from PRIME-MD®, which is a trademark of Pfizer Inc. Copyright © 1999 Pfizer Inc. Reproduced with permission.
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GAD-7
Over the last two weeks, how often have you been bothered by the following problems: (circle
the number that applies to you)

1. Feeling nervous, anxious or on edge
2. Not being able to stop or control
worrying
3. Worrying too much about different
things
4. Trouble relaxing
5. Being so restless that it is hard to sit
still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful
might
happen
If you checked off any problems, how
difficult have these problems made it for
you to do your work, take care of things
at home, or get along with other people?
Total (For health professionals only) =
_____

Not at
all

Several
days

More
than half
the days

Nearly
every day

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

Not
difficult
at all

Somewhat
difficult

Very
difficult

Extremely
Difficult

GAD-7 is from Spitzer, Kroenke, Williams, & Lowe, 2006. Copyright © 2006 Pfizer Inc. Reproduced with permission.	
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Structured Diagnostic Interview for Headache –
Revised (Brief Version)
	
  
	
  
Patient Name:

	
  

Age:

Patient ID:

Sex:

Interviewer:

M

Date:

/

F

/

	
  
The following items are selected from the long version of the Structured Diagnostic Interview for Headache
(SDIH). The SDIH is part of the Headache Evaluation and Diagnostic System (HEDS) which includes software
for data entry and diagnostic decision-making. These materials are intended to facilitate diagnosis of selected
recurrent, benign headaches according to both IHS (2004) and Ad Hoc Committee (1962) diagnostic criteria.
Optimal use of this interview requires expertise with the diagnostic classifications and familiarity with the
computer software and manual that accompany the interview.

	
  
	
  
1. Does the patient get more than one type of headache? 	
  

	
  Yes 	
  

No
Headache #1 #2 #3

(Complete a separate brief interview form for each type of headache)

2. Select all pain locations that apply to this type of headache: (You must check at least one)
	
  frontal (A)

	
  

3. Select all that apply: 	
  

temporal (B)

	
  occipital (C)

top of head (F)

	
  

	
  orbital (D)

base of neck (G)

	
  

	
  supraorbital (E)

	
  nasal/facial (H)

	
  

	
  
	
  
	
   4. What is the intensity of pain that the patient experiences with a typical headache? ____ (Indicate rating from 0-10)
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5. Which of the following symptoms are a “predominant feature” of this headache type (presume that the headache
is untreated)?
Pain Location (Select only one):

Unilateral 	
  

Not Unilateral

Pain Features (Select only one):

Pulsating 	
  

Pressing/Tightening (non-pulsating) 	
  

Other:

6. How often does the patient experience this type of headache pain? ____ d w m y (Indicate frequency in x per day,
week, month,
or year)

7. How long have these headaches been occurring at this rate? ____ Months Years
8. What is the total number of this type of headache ever experienced: 	
  

1 	
  

2-4

	
   5-9 	
  

>10 ____

(Indicate total number experienced)

9. How long does this headache last if untreated or unsuccessfully treated? (If patient falls asleep and wakes up
without headache, duration of attack is until waking up. Check unremitting if patient reports never
experiencing headache less than 7 days in duration). (Indicate duration in minutes, hours, or days)
	
  Unremitting OR
____ m h d Typical Average

____ m h d Typical Minimum

____ m h d Typical Maximum

10. Has anything about this headache (except freq.) changed in the last 6 months?
If YES, explain:

	
  Yes 	
  

No

11. Is the patient’s typical headache pain aggravated by routine physical activities (i.e., walking, lifting, bending, etc.)?
	
  Yes
	
  No
12. Do any of the following symptoms occur with this headache?
	
  Loss of appetite/Anorexia
	
  Headache worsened by conversational noise levels (phonophobia)
	
  Headache worsened by normal light (photophobia)
	
  Nausea (Indicate intensity)
	
  Mild
	
  Moderate
	
  Severe
	
  Vomiting (Indicate intensity)
	
  Mild
	
  Moderate
	
  Severe
13. Does the patient ever experience symptoms before this headache pain begins?
	
  Yes
	
  No
If YES, and if any of the reported symptoms provide evidence of focal cerebral cortical, and/or brainstem
dysfunction, complete Appendix 1
If NO, skip to #14
14. Does this headache have severe unilateral orbital, supraorbital, and/or temporal pain, and/or does the interviewer
suspect a cluster-type headache?
	
  Yes
	
  No
If YES, complete Appendix 2
If NO, skip to #15
15. Does the patient use any medications to relieve headache pain?
If YES, complete #15a, #15b, #15c
If NO, skip to #16

	
  Yes

	
  No

15a. How long has the patient been using the medication(s) to relieve headache pain?
duration in days,

____ d w m y (Indicate

weeks, months, or years)

15b. What is the frequency of medication use?
day

____ days per week

____ days per month

15c. Did this headache develop or markedly worsen during medication overuse?
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  Yes

	
  No

____ times per

	
  
If YES, complete Appendix 3
If NO, skip to #16
16. Is this headache related to any head injury or trauma?
If YES, complete Appendix 4
If NO, skip to #17

	
  Yes

	
  No

17. Is this headache suspected to be attributed to a physical or other neurological disorder?

APPENDIX 1

	
  Yes

	
  No

Migraine Aura Symptoms

	
  
1. How many aura attacks has the patient experienced? ____
2. What best describes the aura symptoms? (Select all that apply)
	
   At least one aura symptom develops gradually over more than 4 minutes, AND/OR 2 or more
symptoms
occur in succession over 4 minutes
	
  Each aura symptom lasts longer than 4 minutes but less than 60 minutes
	
   Headache begins during aura OR follows aura with a headache-free interval of less than 60
minutes
3. Indicate which of the following aura symptoms are present during this type of headache: (Select all that
apply)

	
  

SYMPTOM

X

SYMPTOM

X

	
   Partial loss of sight (scotoma)

	
   Uncoordinated movements (ataxia)

	
   Scintillation

	
   Dizziness (vertigo)

	
   Blurred vision

	
   Ringing in ears (tinnitus)

	
   Fortification spectra (zig-zag lines)

	
   Decreased hearing acuity

	
   Double vision

	
   Decreased level of consciousness

	
   Tingling or numbness (paresthesias)

	
   Aphasia or unclassifiable speech

	
   Weakness (paresis)

	
   Poorly articulated speech (dysarthria)

	
   Other:

	
   Other:
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APPENDIX 2

Cluster Headache Symptoms

1. Have the headaches occurred in cluster periods? 	
  
If YES, complete #1a
If NO, skip to #2

	
  Yes 	
  

	
  No

1a. What is the total number of cluster periods experienced? ____
1b. What is the duration of cluster periods? ____ d w m y (Indicate duration in days, weeks, months, or
years)

2. Are the headaches separated by remission periods? 	
  
If YES, complete #2a
If NO, skip to #3

Yes 	
  

No

2a. What is the duration of remission periods? ____ d w m y (Indicate duration in days, weeks, months, or
years)

3. Indicate which of the following symptoms are present, as well as side affected, during this type of headache:
(Select all
that apply)

X

SYMPTOM

SIDE

SYMPTOM

X

SIDE

	
   Red eyes (conjunctival injection)

R

L

	
   Forehead and facial sweating

R

L

	
   Tearing of the eyes (lacrimation)

R

L

	
   Pupillary constriction (miosis)

R

L

	
   Nasal congestion

R

L

	
   Drooping eyelids (ptosis)

R

L

	
   Runny nose (rhinorrhoea)

R

L

	
   Eyelid swelling (oedema)

R

L

	
   Restlessness or agitation

	
   Other:
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APPENDIX 3
	
  

Medication-Overuse Headache Symptoms

	
  
1. Has the patient withdrawn from the overused medication? 	
  
If YES, complete #1a and #1b
If NO, skip to #2

Yes 	
  

No

1a. Did headache resolve or revert to its previous pattern within 2 months after discontinuation of overused
medication?
Yes 	
   No
1b. Has medication overuse ceased within the last 2 months, but headache has not resolved or reverted
back to its previous pattern? 	
   Yes
	
  No
2. Has intake of ergotamine, triptan, opioid OR combination of ergotamine, triptan, opioid, or analgesic occurred
on 2 or more days per week, for 10 or more days per month, for greater than 3 months (Must not have
combination overuse of any single class alone)?
	
  Yes	
  	
  	
   	
  No
If YES, indicate drug(s): 	
   ergotamine 	
   triptan 	
   opioid
	
  analgesic
_____________________
3. Has the patient’s intake of analgesic occurred on 2 or more days per week, for 15 or more days per month,
for greater than 3 months? 	
   Yes 	
   No
If YES, indicate drug: _____________________
4. Has the patient’s intake of combination analgesics occurred on 2 or more days per week, for 10 or more
days per month, for greater than 3 months?
Yes 	
   No
If YES, indicate drugs:
_______________________________________________________________
5. Has the patient’s intake of medication other than ergotamine, triptan, analgesic, or opioid occurred on a
regular basis for greater than 3 months? 	
   Yes 	
   No
If YES, indicate drug: _____________________
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APPENDIX 4

Post-Traumatic Headache Symptoms

	
  
1. Was there a loss of consciousness associated with head trauma? 	
  
If YES, complete #1a
If NO, skip to #2

Yes 	
  

No

1a. What was the duration of unconsciousness? ____ m h d (Indicate duration in minutes, hours, or days)
2. Is head injury attributed to whiplash? 	
  
If YES, skip #5 through #8
If NO, complete #3 through #8

Yes 	
  

	
  No

3. Did headache develop within 7 days after head trauma (or after regaining consciousness)? 	
  

Yes 	
  

No

4. How long has the headache continued? (Select most representative category)
	
  Resolves within 3 months after head trauma
	
  Persists for greater than 3 months after head trauma
	
  Persists but 3 months have not passed since head trauma
5. Did coma develop? 	
   Yes 	
   No
If YES, indicate severity on Glasgow Coma Scale:
[mild]

	
   GCS <13 [moderate/severe]

6. Did post-traumatic amnesia develop and continue for longer than 48 hours? 	
  
7. Did symptoms/signs develop diagnostic of a concussion? 	
  

Yes 	
  

Yes 	
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No

	
  No

8. Were abnormal neuroimaging results attained suggestive of a traumatic brain lesion? 	
  

	
  

	
   GCS >13

Yes

	
  No
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